The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Malov V.A.

Pervyĭ MGMU im. I.M. Sechenova

Maleev V.V.

FBUN «Tsentral'nyj nauchno-issledovatel'skij institut epidemiologii» Rospotrebnadzora, Moskva

Kozlovskaya N.L.

Department of Nephrology and Hemodialysis, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia;
Research Department of Nephrology, Research Center, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia

Tsvetkova N.A.

Infektsionnaia klinicheskaia bol'nitsa #2 Departamenta zdravookhraneniia Moskvy

Smetanina S.V.

Infectious Clinical Hospital №1 of the Moscow Department of Health, Moscow, Russia

Gorobchenko A.N.

Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia

Serova V.V.

Clinical Infectious Diseases Hospital Two, Moscow Healthcare Department, Moscow, Russia

Chentsov V.B.

Clinical Infectious Diseases Hospital Two, Moscow Healthcare Department, Moscow, Russia

Volkov A.G.

Kafedra bolezneĭ ukha, gorla i nosa Rostovskogo gosudarstvennogo meditsinskogo universiteta Minzdravsotsrazvitiia Rossii, Rostov-na-Donu

Faller A.P.

Clinical Infectious Diseases Hospital Two, Moscow Healthcare Department, Moscow, Russia

Difficulties in the diagnosis of diarrhea-associated hemolytic uremic syndrome in adults

Authors:

Malov V.A., Maleev V.V., Kozlovskaya N.L., Tsvetkova N.A., Smetanina S.V., Gorobchenko A.N., Serova V.V., Chentsov V.B., Volkov A.G., Faller A.P.

More about the authors

Journal: Therapeutic Archive. 2017;89(11): 69‑78

Read: 6575 times


To cite this article:

Malov VA, Maleev VV, Kozlovskaya NL, et al. . Difficulties in the diagnosis of diarrhea-associated hemolytic uremic syndrome in adults. Therapeutic Archive. 2017;89(11):69‑78. (In Russ.)
https://doi.org/10.17116/terarkh2017891169-78

References:

  1. Rozhnova SSh, Khristyukhina OA, Akulova NK, Podkolzin AT. Improvement of a system for monitoring acute enteric infections in the Russian Federation. Epidemiologiya i infektsionnye bolezni. Aktual’nye voprosy. 2014;(2):69-72. (In Russ)
  2. Guerrant RL, Oria R, Bushen OY, Patrick PD, Houpt E, Lima AAM. Global Impact of Diarrheal Diseases That Are Sampled by Travelers: The Rest of the Hippopotamus. Clinical Infectious Diseases. 2005;41(suppl.8):S524-530. https://doi.org/10.1086/432946
  3. Iwamoto M, Ayers T, Mahon BE, Swerdlow DL. Epidemiology of Seafood-Associated Infections in the United States. Clinical Microbiology Reviews. 2010;23(2):399-411. https://doi.org/10.1128/CMR.00059-09
  4. van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. Lancet Neurology. 2008;7(10):939-950. https://doi.org/10.1016/S1474-4422(08)70215-1
  5. Ternhag A, Törner A, Svensson Å, Ekdahl K, Giesecke J. Short- and Long-term Effects of Bacterial Gastrointestinal Infections. Emerging Infectious Diseases. 2008;14(1):143-148. https://doi.org/10.3201/eid1401.070524
  6. Lindsay JA. Chronic Sequelae of Foodborne Disease. Emerging Infectious Diseases. 1997;3(4):443-452. https://doi.org/10.3201/eid0304.970405
  7. Batyushin MM, Rudenko LI, Kozhin AA, Golub VV, Dan’kin ON, Grekova IA. Atypical hemolytic uremic syndrome. Case reports. Nephrology. 2014;18(5):80-84. (In Russ.)
  8. Kozlovskaya NL, Prokopenko EI, Emirova KhM, Serikova SYu. Clinical guidelines for diagnosis and treatment of atypical hemolytic uremic syndrome. Nefrologiya i dializ. 2015;17(3):242-264. (In Russ.)
  9. Tsygin AN, Vashurina TV, Margieva TV, Anan’in PV, Mazo AM, Pushkov AA, Savost’yanov KV. Federal clinical guidelines on rendering help to children with hemolytic uremic syndrome. Pediatric pharmacology. 2015;12(4): 447-455. (In Russ.) https://doi.org/10.15690/pf.v12i4.1427
  10. Krasnova EI, Gaints OV, Loskutova SA, Vasyunin AV. Hemolytic Uremic Syndrome in Acute Intestinal Infections in Children. Detskie infektsii. 2011;(2):63-67. (In Russ.)
  11. Blaser MJ. Bacteria and Diseases of Unknown Cause: Hemolytic-Uremic Syndrome. Journal of Infectious Diseases. 2004;189(3):552-555. https://doi.org/10.1086/381129
  12. Karmali MA, Steele BT, Petric M, Lim C. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet. 1983; 1(8325):619-620.
  13. O’Brien AO, Lively TA, Chen ME, Rothman SW, Formal SB. Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (Shiga) like cytotoxin [letter]. Lancet. 1983;1(8326 Pt1):702.
  14. Karmali MA, Petric M, Lim C, Fleming PC, Steele BT. Escherichia coli cytotoxin, haemolytic-uraemic syndrome, and haemorrhagic colitis. Lancet. 1983;2(8362):1299-1300.
  15. Kagan MYu. Hemolytic-uremic syndrome associated with pneumococcal infection. Review. Nefrologiya i dializ. 2013;15(2):116-119. (In Russ.)
  16. Moriel DG, Rosini R, Seib KL, Serino L, Pizza M, Rappuoli R. Escherichia coli: Great Diversity around a Common Core. mBio. 2012;3(3):e00118-12. https://doi.org/10.1128/mBio.00118-12
  17. Bettelheim KA, Goldwater PN. Serotypes of Non-O157 Shigatoxigenic Escherichia coli (STEC). Advances in Microbiology. 2014;4(7):377-389. https://doi.org/10.4236/aim.2014.47045
  18. Miko A, Delannoy S, Fach P, Strockbine NA, Lindstedt BA, Mariani-Kurkdjian P, Reetz J, Beutin L. Genotypes and Virulence Characteristics of Shiga Toxin-Producing Escherichia coli O104 Strains from Different Origins and Sources. International Journal of Medical Microbiology. 2013;303(8):410-421. https://doi.org/10.1016/j.ijmm.2013.05.006
  19. WHO. Outbreaks of E. coli O104:H4 infection. 2011. Available at: http://www.euro.who.int/en/countries/germany/outbreaks-of-e.-coli-o104h4-infection
  20. Onishchenko GG, Dyatlov IA, Svetoch EA, Volozhantsev NV, Bannov VA, Kartsev NN, Borzenkov VN, Fursova NK, Shemyakin IG, Bogun AG, Kislichkina AA, Popova AV, Myakinina VP, Teimurazov MG, Polosenko OV, Kaftyreva LA, Makarova MA, Matveeva ZN, Grechaninova TA, Grigor’eva NS, Kicha EV, Zabalueva GV, Kutasova TB, Korzhaev YuN, Bashketova NS, Bushmanova ON, Stalevskayа AV, Tchinjeria IG, Zhebrun FB. Molecular-genetic Characterization of Shiga-Toxin Producing Escherichia Coli Isolated During a Food-Borne Outbreak in St. Petersburg in 2013. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk. — Annals of the Russian Academy of Medical Sciences. 2015;70(1):70-81. (In Russ.) https://doi.org/10.15690/vramn.v70i1.1234
  21. Podkolzin AT, Konovalova TA, Veselova OA. Evaluation of the efficiency of diagnostic regimens for enterohemorrhagic escherichiasis. Etiological verification of hemolytic uremic syndrome in the Russian Federation. Terapevticheskij arkhiv. 2014;86(11):66-69. (In Russ)
  22. Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, Jones JL, Griffin PM. Foodborne Illness Acquired in the United States—Major Pathogens. Emerging Infectious Diseases. 2011;17(1):7-15. https://doi.org/10.3201/eid1701.P11101
  23. Diez-Gonzalez F, Callaway TR, Kizoulis MG, Russell JB. Grain feeding and the dissemination of acid-resistant Escherichia coli from cattle. Science. 1998;281(5383):1666—1668. https://doi.org/10.1126/science.281.5383.1666
  24. Cody SH, Glynn MK, Farrar JA, Cairns KL, Griffin PM, Kobayashi J, Fyfe M, Hoffman R King AS, Lewis JH, Swaminathan B, Bryant RG, Vugia DJ. An outbreak of Escherichia coli О157:H7 infection from unpasteurized commercial apple juice. Annals of Internal Medicine. 1999;130(3):202-209.
  25. Lu HJ, Breidt F, Perez-Diaz IM, Osborne JA. Antimicrobial Effects of Weak Acids on the Survival of Escherichia coli O157:H7 under Anaerobic Conditions. Journal of Food Protection. 2011;74(6):893-898. https://doi.org/10.4315/0362-028X.JFP-10-404
  26. Frankel G, Phillips AD. Attaching effacing Escherichia coli and paradigms of tir-triggered actin polymerization: Getting off the pedestal. Cellular Microbiology. 2008;10(3):549-556. https://doi.org/10.1111/j.1462-5822.2007.01103.x
  27. Brigotti M, Tazzari PL, Ravanelli E, Carnicelli D, Rocchi L, Arfilli V, Scavia G, Minelli F, Ricci F, Pagliaro P, Ferretti AV, Pecoraro C, Paglialonga F, Edefonti A, Procaccino MA, Tozzi AE, Caprioli A. Clinical relevance of shiga toxin concentrations in the blood of patients with hemolytic uremic syndrome. Pediatric Infectious Disease Journal. 2011;30(6):486-490. https://doi.org/10.1097/INF.0b013e3182074d22
  28. Zoja C, Buelli S, Morigi M. Shiga toxin-associated hemolytic uremic syndrome: Pathophysiology of endothelial dysfunction. Pediatric Nephrology. 2010;25(11):2231-2240. https://doi.org/10.1007/s00467-010-1522-1
  29. Nolasco LH, Turner NA, Bernardo A, Tao Z, Cleary TG, Dong JF, Moake JL. Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers. Blood. 2005;106(13):4199-4209. https://doi.org/10.1182/blood-2005-05-2111
  30. Orth D, Wurzner R. Complement in typical hemolytic uremic syndrome. Seminars in Thrombosis and Hemostasis. 2010;36(6):620-624. https://doi.org/10.1055/s-0030-1262883
  31. Trachtman H, Austin C, Lewinski M, Stahl RA. Renal and neurological involvement in typical Shiga toxin-associated HUS. Nature Reviews Nephrology. 2012;8(11):658-669. https://doi.org/10.1038/nrneph.2012.196
  32. Karmali MA, Mascarenhas M, Petric M, Dutil L, Rahn K, Ludwig K, Arbus GS, Michel P, Sherman PM, Wilson J, Johnson R, Kaper JB. Age-specific frequencies of antibodies to Escherichia coli verocytotoxins (Shiga toxins) 1 and 2 among urban and rural pulations in Southern Ontario. Journal of Infectious Diseases. 2003;188(11):1724-1729. https://doi.org/10.1086/379726
  33. Siegler RL. Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome. Journal of Pediatrics. 1994;125(4): 511-518.
  34. Oakes RS, Siegler RL, McReynolds MA, Pysher T, Pavia AT. Predictors of fatality in postdiarrheal hemolytic uremic syndrome. Pediatrics. 2006;117(5):1656-1662. https://doi.org/10.1542/peds.2005-0785
  35. Cornick NA, Jelacic S, Ciol MA, Tarr PI. Escherichia coli O157:H7 infections: discordance between filterable fecal Shiga toxin and disease outcome. Journal of Infectious Diseases. 2002;186(1):57-63. https://doi.org/10.1086/341295
  36. Grif K, Dierich MP, Karch H, Allerberger F. Strain-specific differences in the amount of Shiga toxin released from enterohemorrhagic Escherichia coli O157 following exposure to subinhibitory concentrations of antimicrobial agents. European Journal of Clinical Microbiology a. Infectious Diseases. 1998;17(11):761-766.
  37. Freedman SB, Xie J, Neufeld MS, Hamilton WL, Hartling L, Tarr PhI. Shiga Toxin—Producing Escherichia coli Infection, Antibiotics, and Risk of Developing Hemolytic Uremic Syndrome: A Meta-analysis. Clinical Infectious Diseases. 2016;62(10):1251-1258. https://doi.org/10.1093/cid/ciw099
  38. Cimolai N, Morrison BJ, Carter JE. Risk factors for the central nervous system manifestations of gastroenteritis-associated hemolyticuremic syndrome. Pediatrics. 1992;90(4):616-621.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.